Boehringer Ingelheim

E871479

Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.

All labels observed (4)

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf animal health company
pharmaceutical company
country Germany
develops animal health products
biopharmaceuticals
prescription medicines
focusesOn cardiovascular diseases
central nervous system diseases
immunology
metabolic diseases
oncology
respiratory diseases
foundedBy Albert Boehringer
hasBusinessSegment animal health
biopharmaceutical contract manufacturing
human pharmaceuticals
hasManufacturingSiteIn Brazil
China
Germany
Spain
United States
hasNumberOfEmployeesOver 50000
hasResearchSiteIn France
Germany
Japan
United States
hasSubsidiary Boehringer Ingelheim Animal Health
headquartersLocation Germany
Ingelheim am Rhein
Rhineland-Palatinate
inception 1885
industry animal health industry
biotechnology industry
pharmaceutical industry
isAmong largest pharmaceutical companies in the world
isFamilyOwned true
isResearchDriven true
legalForm Kommanditgesellschaft
notableProduct Jardiance
Micardis
Ofev
Pradaxa
linked to: dabigatran

Spiriva
Trajenta
scopeOfOperations global
website https://www.boehringer-ingelheim.com/

How these facts were elicited

Referenced by (8)

Full triples — surface form annotated when it differs from this entity's canonical label.

Ingelheim am Rhein hasCompanyHeadquarters Boehringer Ingelheim
Biberach an der Riß hasMajorEmployer Boehringer Ingelheim
Skyrizi coDevelopedBy Boehringer Ingelheim
idarucizumab hasDeveloper Boehringer Ingelheim
RE-LY trial sponsor Boehringer Ingelheim
Boehringer Ingelheim hasSubsidiary Boehringer Ingelheim Animal Health
linked to: Boehringer Ingelheim
Heinrich Wieland Prize formerSponsor C.H. Boehringer Sohn
linked to: Boehringer Ingelheim
Heinrich Wieland Prize formerSponsor Boehringer Ingelheim GmbH
linked to: Boehringer Ingelheim